Home
Charts
Search
Watchlist
Products
All IPOs
₹70 - 70
Hannah Joseph Hospital Ltd
HealthcareIPOSME
₹70 - 70
With an objective to provide comprehensive range of neurosurgery and neurology services, Mosesjoseph Arunkumar established a hospital in the name of `Hannah Joseph Hospital' as a sole proprietorship in Madurai town of Tamil Nadu, in 2008. On September 9, 2008, the hospital became a member of Nursing Homes and Hospital Board, Indian Medical Association Tamil Nadu State.
Lot2,000Min Invest₹2,80,000Face Value₹10Issue Size₹42 CrFresh Issue₹42 CrListing Price₹65CMP₹92
Timeline
22 Jan
Bidding opens
28 Jan
Bidding closes
29 Jan
Allotment
30 Jan
Refund & demat credit
2 Feb
Listing
Subscription
Subscription opens once dates are announced
Reports
Offer Details
Terms
Issue Size₹42 Cr0.60 Cr shares
Fresh Issue₹42 Cr
Face Value₹10
Lot Size2,000 shares
ReservationQIB 50% · NII 15% · RETAIL 35%
Application Sizes
Retail₹2,80,0001-1 lots
sNII₹2,80,000from 2 lots
bNII₹11,20,000from 8 lots
Managers & Registrar
Lead ManagerCapitalSquare Advisors Pvt Ltd
RegistrarBigshare Services Pvt Ltd
Ownership & Proceeds
Shareholding
CategoryPre IPOPost IPOPromoter Group93.57%68.83%Public6.43%31.17%
Objects of the Issue
- Funding of capital expenditure for establishing Radiation Oncology Centre
- General Corporate purpose
Financials
Profit & Loss
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| RevenueCr | 58 | 55 | 63 | 78 | 92 |
| Operating ProfitCr | 18 | 17 | 18 | 21 | 25 |
| OPM% | 31.4 | 30.3 | 28.6 | 26.7 | 27.4 |
| PBTCr | 0 | 1 | 5 | 10 | 16 |
| PATCr | 0 | 1 | 4 | 7 | 11 |
| EPS | 1 | 1 | 2 | 4 | 6 |
Balance Sheet
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity CapitalCr | 11 | 16 | 17 | 17 | 23 |
| ReservesCr | 14 | 18 | 29 | 35 | 75 |
| BorrowingsCr | 51 | 43 | 32 | 37 | 27 |
| Total AssetsCr | 86 | 92 | 90 | 97 | 133 |
Cash Flow
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Operating Cash FlowCr | 15 | 21 | 8 | 19 | 21 |
| Investing Cash FlowCr | 0 | -5 | -4 | -14 | -14 |
| Financing Cash FlowCr | -14 | -10 | -3 | -3 | 25 |
| Net Cash FlowCr | 1 | 5 | 2 | 3 | 32 |
Strengths & Risks
Strengths · as stated in the DRHP
- Founder led company supported by a highly experienced and professional management team.
- Company is reputed for providing quality health care and wellness.
- High consistency and success rates in handling complicated surgeries.
- Growth opportunities in existing facilities and diversification into new services.
- Ability to attract and retain high quality doctors, consultants and medical support staff.
Strategies · as stated in the DRHP
- Commitment to Excellence in Healthcare Services.
- Skilled Medical Team and Retention Strategy.
- Strategic Location and Expansion Focus.
- Infrastructure and Machinery used in the Hospital.
- Enhancing Operational Excellence.
Risks · as stated in the DRHP
- We intend to utilize a portion of the Net Proceeds for setting up the Proposed Radiation Oncology Centre adjacent to the current hospital campus. We are yet to place orders for medical equipments and apply for requisite government approvals for the Proposed Radiation Oncology Centre. If we are unable to commission our Proposed Radiation Oncology Centre without time and cost overruns or unable to adhere to the schedule of implementation it may adversely affect our business, results of operations and financial conditions.
- We are required to obtain statutory and regulatory approvals, licenses or permits for our proposed radiation oncology centre. If we fail to obtain, maintain or renew our statutory and regulatory approvals or permits, our business, results of operations, financial condition, and cash flows could be adversely affected.
- There are outstanding legal proceedings involving our Company. Any adverse decisions could impact our net worth, profitability, cashflows and divert management time and attention and have an adverse effect on our business, prospects, results of operations and financial condition.
- Our Company did not open a separate bank account for private placements made in the past, utilized the proceeds from the issuance prior filing of Form PAS- 3, and issued private placement offer cum application letter before filing the Form MGT-14 with registrar and determined the relevant date within 30 days prior to the date of general meeting in violation of Section 42 of the Companies Act, 2013 and the rules made thereunder, which may have a material adverse effect on our business.
- There may have been certain instances of irregularities, discrepancies and non-compliances with respect to certain corporate actions taken by our Company in the past. Consequently, we may be subject to regulatory actions and penalties.
- Our company failed to obtain prior shareholder approval for a loan conversion option as required under Section 62(3) of the Companies Act, 2013 nor did it obtain the necessary valuation report for the same.